Table 2.
Height |
Height and lean mass |
Height and lean and fat mass |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
β | 95% CI | p | β | 95% CI | p | β | 95% CI | p | |||||
TBLH | BMC | 4.02 | −0.50 | 8.53 | 0.08 | −0.47 | −4.10 | 3.16 | 0.8 | 14.92 | 11.80 | 18.05 | <0.001 |
Area | −1.98 | −5.23 | 1.26 | 0.2 | −5.04 | −7.72 | −2.37 | <0.001 | 7.82 | 5.65 | 9.98 | <0.001 | |
BMD | 4.52 | 3.09 | 5.96 | <0.001 | 3.26 | 2.04 | 4.48 | <0.001 | 5.90 | 4.70 | 7.11 | <0.001 | |
aBMC | 6.46 | 4.88 | 8.04 | <0.001 | 5.74 | 4.22 | 7.25 | <0.001 | 5.30 | 3.75 | 6.86 | <0.001 | |
Upper Limb |
BMC | 0.55 | −0.11 | 1.22 | 0.1 | −0.13 | −0.65 | 0.40 | 0.6 | 1.05 | 0.53 | 1.57 | <0.001 |
Area | 0.18 | −0.49 | 0.86 | 0.6 | −0.47 | −1.02 | 0.08 | 0.09 | 0.81 | 0.27 | 1.34 | 0.003 | |
BMD | 1.86 | 0.74 | 2.99 | 0.001 | 0.94 | −0.04 | 1.92 | 0.06 | 2.10 | 1.11 | 3.10 | <0.001 | |
aBMC | 0.39 | 0.16 | 0.62 | <0.001 | 0.29 | 0.06 | 0.51 | 0.01 | 0.34 | 0.11 | 0.56 | 0.003 | |
Lower Limb |
BMC | 3.53 | 1.39 | 5.67 | 0.001 | 1.39 | −0.32 | 3.10 | 0.1 | 9.44 | 8.04 | 10.84 | <0.001 |
Area | −0.24 | −1.41 | 0.92 | 0.7 | −1.29 | −2.27 | −0.31 | 0.01 | 3.72 | 2.95 | 4.48 | <0.001 | |
BMD | 6.75 | 4.64 | 8.85 | <0.001 | 5.01 | 3.18 | 6.84 | <0.001 | 9.42 | 7.63 | 11.20 | <0.001 | |
aBMC | 3.90 | 2.76 | 5.05 | <0.001 | 3.36 | 2.26 | 4.46 | <0.001 | 3.74 | 2.62 | 4.87 | <0.001 |
Analyses were adjusted for height, height and lean mass, and height and lean and fat mass (n = 4457). β reflects the change in DXA outcome per 100 cpm increase in activity level (height included both linear and quadratic terms).